Demographic and clinical characteristics
| . | Total (N = 343) . | |
|---|---|---|
| n . | % . | |
| Participating study | ||
| Study 1 | 57 | 16.6 |
| Study 2 | 147 | 42.8 |
| Study 3 | 57 | 16.6 |
| Study 4 | 54 | 15.7 |
| Intensive treatment | ||
| Intensive | 244 | 71.1 |
| Lower-intensity | 99 | 28.8 |
| White race | ||
| No | 33 | 9.6 |
| Yes | 310 | 90.3 |
| Ethnicity | ||
| missing | 5 | 1.4 |
| Hispanic | 17 | 4.9 |
| Non-Hispanic | 321 | 93.5 |
| Gender | ||
| Female | 131 | 38.1 |
| Male | 212 | 61.8 |
| Married | ||
| No | 87 | 25.3 |
| Yes | 256 | 74.6 |
| Educational attainment | ||
| Some college or less | 162 | 47.2 |
| College graduate | 181 | 52.7 |
| Annual income | ||
| missing | 29 | 8.4 |
| <25 000 | 34 | 9.9 |
| $25 000-$50 000 | 74 | 21.5 |
| $50 000-$100 000 | 104 | 30.3 |
| $101 000-$150 000 | 45 | 13.1 |
| ≥150 000 | 57 | 16.6 |
| AML risk score | ||
| Favorable | 32 | 9.3 |
| Intermediate | 178 | 51.8 |
| Adverse | 133 | 38.7 |
| Death at last follow-up | ||
| Dead | 199 | 58.0 |
| Alive or unknown | 144 | 41.9 |
| Mean | SD | |
| Age at baseline, y | 69.46 | 12.14 |
| HADS depression score at baseline | 5.48 | 3.82 |
| HADS anxiety score at baseline | 5.85 | 4.08 |
| FACT-PWB at baseline | 19.91 | 5.77 |
| Follow-up for FACT-PWB, d | 113.69 | 63.56 |
| . | Total (N = 343) . | |
|---|---|---|
| n . | % . | |
| Participating study | ||
| Study 1 | 57 | 16.6 |
| Study 2 | 147 | 42.8 |
| Study 3 | 57 | 16.6 |
| Study 4 | 54 | 15.7 |
| Intensive treatment | ||
| Intensive | 244 | 71.1 |
| Lower-intensity | 99 | 28.8 |
| White race | ||
| No | 33 | 9.6 |
| Yes | 310 | 90.3 |
| Ethnicity | ||
| missing | 5 | 1.4 |
| Hispanic | 17 | 4.9 |
| Non-Hispanic | 321 | 93.5 |
| Gender | ||
| Female | 131 | 38.1 |
| Male | 212 | 61.8 |
| Married | ||
| No | 87 | 25.3 |
| Yes | 256 | 74.6 |
| Educational attainment | ||
| Some college or less | 162 | 47.2 |
| College graduate | 181 | 52.7 |
| Annual income | ||
| missing | 29 | 8.4 |
| <25 000 | 34 | 9.9 |
| $25 000-$50 000 | 74 | 21.5 |
| $50 000-$100 000 | 104 | 30.3 |
| $101 000-$150 000 | 45 | 13.1 |
| ≥150 000 | 57 | 16.6 |
| AML risk score | ||
| Favorable | 32 | 9.3 |
| Intermediate | 178 | 51.8 |
| Adverse | 133 | 38.7 |
| Death at last follow-up | ||
| Dead | 199 | 58.0 |
| Alive or unknown | 144 | 41.9 |
| Mean | SD | |
| Age at baseline, y | 69.46 | 12.14 |
| HADS depression score at baseline | 5.48 | 3.82 |
| HADS anxiety score at baseline | 5.85 | 4.08 |
| FACT-PWB at baseline | 19.91 | 5.77 |
| Follow-up for FACT-PWB, d | 113.69 | 63.56 |
HADS, Hospital Anxiety and Depression Scale.